Related Experiment Videos
Human brain endothelial cells supply support for monocyte immunoregulatory functions
Rosanne Séguin1, Zacharo Moditi, Ronny Rotondo
1Neuroimmunology Unit, Montréal Neurological Institute, 3801 University, H3B 2A4, Montreal, Quebec, Canada.
Journal of Neuroimmunology
|February 11, 2003
Summary
Human brain endothelial cells support monocyte immune functions during CNS inflammation. Interferon-beta inhibits monocyte migration across these barriers, impacting inflammatory responses.
Area of Science:
- Neuroimmunology
- Endothelial Cell Biology
- Monocyte Function
Background:
- Monocytes are key immune cells in central nervous system (CNS) inflammation.
- Interaction between blood monocytes and brain endothelial cells is critical for CNS immune responses.
- Understanding these interactions is vital for developing treatments for neuroinflammatory diseases.
Purpose of the Study:
- To investigate the immune function of human blood-derived monocytes after interacting with human brain-derived endothelial cells (HBECs).
- To determine how HBECs influence monocyte antigen-presenting capacity and cytokine production.
- To assess the effect of interferon-beta on monocyte migration across HBECs.
Main Methods:
- Utilized Boyden chambers with HBEC-coated membranes to model the blood-brain barrier.
- Assessed immune function, including antigen-presenting capacity and chemokine/cytokine production, of monocytes.
- Monitored monocyte migration across the HBEC barrier, with and without interferon-beta treatment.
Main Results:
- Monocytes in direct contact with HBECs retained their antigen-presenting capacity and chemokine/cytokine production.
- Monocytes that migrated through the HBEC barrier showed diminished functional properties.
- Interferon-beta significantly inhibited monocyte migration across the HBEC barrier.
Conclusions:
- HBECs support the functional integrity of perivascular monocytes during CNS inflammation, despite not being competent antigen-presenting cells themselves.
- HBECs play a crucial role in modulating monocyte immune functions within the CNS.
- Interferon-beta represents a potential therapeutic target for controlling monocyte infiltration in CNS inflammatory conditions.